Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Search by expertise, name or affiliation
Adjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma: Results From the Upper Tract Urothelial Carcinoma Collaboration
Nicholas J. Hellenthal
, Shahrokh F. Shariat
, Vitaly Margulis
, Pierre I. Karakiewicz
, Marco Roscigno
, Christian Bolenz
, Mesut Remzi
, Alon Weizer
, Richard Zigeuner
, Karim Bensalah
, Casey K. Ng
,
Jay Raman
, Eiji Kikuchi
, Francesco Montorsi
, Mototsugu Oya
, Christopher G. Wood
, Mario Fernandez
, Christopher P. Evans
, Theresa M. Koppie
Department of Surgery
Penn State Cancer Institute
Cancer Institute, Cancer Control
Department of Urology
Research output
:
Contribution to journal
›
Article
›
peer-review
199
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Adjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma: Results From the Upper Tract Urothelial Carcinoma Collaboration'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adjuvant Chemotherapy
100%
Age Groups
11%
Cancer-specific Survival
55%
Clinical High Risk
22%
Collaborative Database
11%
Group Performance
11%
High Risk
100%
Kaplan-Meier Analysis
11%
Lymph Node Positive
11%
Median Survival
11%
Minimal Impact
11%
Nephroureterectomy
33%
No Significant Difference
11%
Performance Status
22%
Significant Predictors
11%
Tumor Grade
33%
Tumor Stage
33%
Upper Tract Urothelial Carcinoma
100%
Medicine and Dentistry
Adjuvant Chemotherapy
100%
Cancer Specific Survival
55%
Kaplan Meier Method
11%
Lymph Node
11%
Neoplasm
33%
Nephroureterectomy
33%
Transitional Cell Carcinoma
100%